Stock Events

Stock Events

Anixa Biosciences 

$3.08
71
+$0.03+0.82% 19:59 Today

Statistics

Day High
3.08
Day Low
3.06
52W High
5.22
52W Low
2.35
Volume
2,946
Avg. Volume
-
Mkt Cap
104.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11SepExpected
Q4 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
Next
-0.1
-0.09
-0.08
-0.07
Expected EPS
-0.0818
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-10.93MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ANIX. It's not an investment recommendation.
NVIDIA
8
NVDA
AT&T
6
T
Palantir Technologies
6
PLTR
Coca-Cola
5
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in areas similar to Anixa, including oncology, making it a direct competitor.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that produces cancer treatments and vaccines, competing in the oncology and immunotherapy spaces like Anixa.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb operates in the biopharmaceutical field focusing on cancer, a key area for Anixa, making them competitors in developing treatments for various cancers.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech company focusing on human therapeutics, including oncology and inflammation, areas where Anixa is also aiming to make significant contributions.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is involved in the discovery, development, and manufacture of healthcare products including cancer treatments, directly competing with Anixa's focus areas.
Novartis
NVS
Mkt Cap292.35B
Novartis AG focuses on patented medicines for a range of diseases, including cancer, directly competing with Anixa in the oncology research and development space.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in pharmaceuticals and diagnostics with a strong focus on oncology, making it a competitor to Anixa in cancer research and treatment.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC is a biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with Anixa.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, including cancer treatments, competing with Anixa.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for treating serious medical conditions, including cancer, similar to Anixa's focus.

About

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Show more...
CEO
Amit Kumar
Employees
4
Country
United States
ISIN
US03528H1095
WKN
000A2N6ZF

Listings

STU
DE
CY71.STU
MU
DE
CY71.MU
BOATS
BOATS
ANIX.BOATS
XNAS
US
ANIX

0 Comments

Share your thoughts

FAQ

What is Anixa Biosciences stock price today?▼
The current price of ANIX is $3.08 USD — it has increased by +0.82% in the past 24 hours. Watch Anixa Biosciences stock price performance more closely on the chart.
What is Anixa Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Anixa Biosciences stocks are traded under the ticker ANIX.
Is Anixa Biosciences stock price growing?▼
ANIX stock has fallen by -11.64% compared to the previous week, the month change is a -9.82% fall, over the last year Anixa Biosciences has showed a +3.54% increase.
What is Anixa Biosciences market cap?▼
Today Anixa Biosciences has the market capitalization of 104.62M
When is the next Anixa Biosciences earnings date?▼
Anixa Biosciences is going to release the next earnings report on September 11, 2026.
What were Anixa Biosciences earnings last quarter?▼
ANIX earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.09 USD resulting in a +14.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Anixa Biosciences revenue for the last year?▼
Anixa Biosciences revenue for the last year amounts to 0 USD.
What is Anixa Biosciences net income for the last year?▼
ANIX net income for the last year is -10.93M USD.
How many employees does Anixa Biosciences have?▼
As of September 04, 2026, the company has 4 employees.
In which sector is Anixa Biosciences located?▼
Anixa Biosciences operates in the Health & Wellness sector.
When did Anixa Biosciences complete a stock split?▼
The last stock split for Anixa Biosciences was on June 26, 2015 with a ratio of 1:25.
Where is Anixa Biosciences headquartered?▼
Anixa Biosciences is headquartered in SAN JOSE, United States.